Anderson University will launch three new academic programs in fall 2026, expanding its curriculum to better serve both ...

Since scientists first discovered that human immune cells could be modified to become cancer-fighting agents, they've been trying to engineer a cell that's effective against solid tumors, which ...

The Gene Synthesis Market has emerged as one of the most transformative segments within modern biotechnology, driven by rapid ...

Vector-borne diseases (VBDs) represent a critical challenge in infectious disease control due to their complex transmission dynamics, diverse vector ...

"Devyn brings a rare combination of scientific depth, operational leadership, and strategic perspective," said Nazli Azimi, Ph.D., Chief Executive Officer of Therna. "His experience across genetic ...

Abstract: Machine translation and post-editing (MTPE) in the language service industry is widely recognized with the development of machine translation (MT) technology and the increase in global ...

Learn more about the cutting-edge technology that enables 3D printing inside living cells and what that means for the ...

New six-part webinar series on genetic causes of cerebral palsy launches Wednesday We are excited to partner with ...

Beam is advancing BEAM-304 using an approach in which multiple mutation-specific base editors are developed within a single clinical program.

"Gene editing takes centre stage in FDA’s new rare disease approval pathway" was originally created and published by ...

According to Morgan O’Gara of Blackrock Dental, dentists’ surgeries are no longer the austere, clinical spaces they used to be. “The traditional kind of ‘up the stairs, two surgery’ practices are gone ...

Researchers have found that a new base-editing gene therapy can help treat a rare neurodevelopmental disorder called Snijders Blok–Campeau syndrome caused by mutations in the CHD3 gene. A specialized ...